We show, in line with our previous findings 16 and with the literature 19, that crosslinking of HER2 at the plasma membrane can enhance the endocytic degradation of HER2 in Tz-sensitive breast cancer cell lines. This evidence concerns the gene ERBB2 and breast carcinoma.